
Early-stage biotech developing microbial gut therapies for inflammatory diseases.
Industry: Health Care
First Day Return: +1.6%

| IPO Date | 05/08/2018 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $85 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | Cambridge, MA, United States |
|---|---|
| Founded | 2014 |
| Employees at IPO | 59 |
| Website www.evelobio.com | |